275 related articles for article (PubMed ID: 28445005)
1. Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalinin.
Dyshlovoy SA; Otte K; Venz S; Hauschild J; Junker H; Makarieva TN; Balabanov S; Alsdorf WH; Madanchi R; Honecker F; Bokemeyer C; Stonik VA; von Amsberg G
Proteomics; 2017 Jun; 17(11):. PubMed ID: 28445005
[TBL] [Abstract][Full Text] [Related]
2. Marine compound rhizochalinin shows high in vitro and in vivo efficacy in castration resistant prostate cancer.
Dyshlovoy SA; Otte K; Alsdorf WH; Hauschild J; Lange T; Venz S; Bauer CK; Bähring R; Amann K; Mandanchi R; Schumacher U; Schröder-Schwarz J; Makarieva TN; Guzii AG; Tabakmakher KM; Fedorov SN; Shubina LK; Kasheverov IE; Ehmke H; Steuber T; Stonik VA; Bokemeyer C; Honecker F; von Amsberg G
Oncotarget; 2016 Oct; 7(43):69703-69717. PubMed ID: 27626485
[TBL] [Abstract][Full Text] [Related]
3. Rhizochalinin Exhibits Anticancer Activity and Synergizes with EGFR Inhibitors in Glioblastoma In Vitro Models.
Dyshlovoy SA; Hauschild J; Venz S; Krisp C; Kolbe K; Zapf S; Heinemann S; Fita KD; Shubina LK; Makarieva TN; Guzii AG; Rohlfing T; Kaune M; Busenbender T; Mair T; Moritz M; Poverennaya EV; Schlüter H; Serdyuk V; Stonik VA; Dierlamm J; Bokemeyer C; Mohme M; Westphal M; Lamszus K; von Amsberg G; Maire CL
Mol Pharm; 2023 Oct; 20(10):4994-5005. PubMed ID: 37733943
[TBL] [Abstract][Full Text] [Related]
4. Anti-migratory activity of marine alkaloid monanchocidin A - proteomics-based discovery and confirmation.
Dyshlovoy SA; Venz S; Hauschild J; Tabakmakher KM; Otte K; Madanchi R; Walther R; Guzii AG; Makarieva TN; Shubina LK; Fedorov SN; Stonik VA; Bokemeyer C; Balabanov S; Honecker F; V Amsberg G
Proteomics; 2016 May; 16(10):1590-603. PubMed ID: 27001414
[TBL] [Abstract][Full Text] [Related]
5. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
[TBL] [Abstract][Full Text] [Related]
6. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
[TBL] [Abstract][Full Text] [Related]
8. The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer.
Dyshlovoy SA; Menchinskaya ES; Venz S; Rast S; Amann K; Hauschild J; Otte K; Kalinin VI; Silchenko AS; Avilov SA; Alsdorf W; Madanchi R; Bokemeyer C; Schumacher U; Walther R; Aminin DL; Fedorov SN; Shubina LK; Stonik VA; Balabanov S; Honecker F; von Amsberg G
Int J Cancer; 2016 May; 138(10):2450-65. PubMed ID: 26695519
[TBL] [Abstract][Full Text] [Related]
9. The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells.
Heidarian E; Keloushadi M; Ghatreh-Samani K; Valipour P
Biomed Pharmacother; 2016 Dec; 84():264-269. PubMed ID: 27665471
[TBL] [Abstract][Full Text] [Related]
10. Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
Wang X; Niu Z; Jia Y; Cui M; Han L; Zhang Y; Liu Z; Bi D; Liu S
Oncol Rep; 2016 Apr; 35(4):2121-30. PubMed ID: 26846372
[TBL] [Abstract][Full Text] [Related]
11. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.
Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y
Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591
[TBL] [Abstract][Full Text] [Related]
12. An ion-current-based, comprehensive and reproducible proteomic strategy for comparative characterization of the cellular responses to novel anti-cancer agents in a prostate cell model.
Tu C; Li J; Bu Y; Hangauer D; Qu J
J Proteomics; 2012 Dec; 77():187-201. PubMed ID: 22982362
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
14. LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression.
Wang H; Shi J; Luo Y; Liao Q; Niu Y; Zhang F; Shao Z; Ding Y; Zhao L
Clin Cancer Res; 2014 Nov; 20(22):5835-47. PubMed ID: 25252758
[TBL] [Abstract][Full Text] [Related]
15. [Influence of phosphoprotein associated with glycosphingolipid microdomains 1 on biologic behavior of human prostatic cancer cell line in-vitro].
Yu WJ; Wang YW; You JF; Wang JL; Cui XL; Pei F; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):615-20. PubMed ID: 21092590
[TBL] [Abstract][Full Text] [Related]
16. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
[TBL] [Abstract][Full Text] [Related]
17. LASP1 in Tumor and Tumor Microenvironment.
Hu Z; Wang X; Cui Y; Li C; Wang S
Curr Mol Med; 2017; 17(8):541-548. PubMed ID: 29473505
[TBL] [Abstract][Full Text] [Related]
18. GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells.
Karanika S; Karantanos T; Kurosaka S; Wang J; Hirayama T; Yang G; Park S; Golstov AA; Tanimoto R; Li L; Thompson TC
Mol Cancer; 2015 Jun; 14():122. PubMed ID: 26084402
[TBL] [Abstract][Full Text] [Related]
19. Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-κB pathway.
Sun W; Guo L; Shao G; Liu X; Guan Y; Su L; Zhao S
Oncol Rep; 2017 Jan; 37(1):341-347. PubMed ID: 27840958
[TBL] [Abstract][Full Text] [Related]
20. Proteomic exploration of the impacts of pomegranate fruit juice on the global gene expression of prostate cancer cell.
Lee ST; Wu YL; Chien LH; Chen ST; Tzeng YK; Wu TF
Proteomics; 2012 Nov; 12(21):3251-62. PubMed ID: 22945439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
